Intrinsiqq
NervGen Pharma Corp. logo

NervGen Pharma Corp. Insider Trading

NGEN

Compare

NervGen Pharma Corp.'s insiders don't report trades to the SEC

Insider trades on this page come from SEC Form 4 filings. NGEN is a company from outside the US, so its directors report their trades to the market regulator in its home country instead, and there are no Form 4 filings to show. This is the case for most companies listed outside the US, and for foreign companies with US-listed shares.

See what insiders are buying in US companies

Open-market buys by executives and directors, from today's SEC filings.

Insider buys

Peers

Biotechnology · Pick stocks to compare with NGEN

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Held by ETFs

NGEN is in 1 US ETF. The largest of them, with NGEN's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NGEN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.